IMCAS World Congress 2020 January 30 – February 2 in Paris
Estar medical is delighted to take part in the IMCAS congress that has targeted effective aging...
Regenlab is in Breach of UK Court Orders Following Revocation of its PRP Patent
Regen Lab SA (Regenlab) has failed to pay legal costs ordered by the UK High Court after revocation of its PRP patent for lack of novelty and inventive step. Regenlab is exposed to enforcement procedures which may limit its ability to provide products in the marketplace...
5CC Aesthetics Conference – Barcelona, Spain – August 2019
Estar Medical is delighted to take part in the 5CC aesthetics conference and exhibition. One of the top lasers and aesthetic meetings in the world. You're welcome to visit our team in booth #58 and learn more about our new innovations in the PRP and autologous cell therapy fields...
European Patent Office revoked Regenlab PRP patent
Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step...
TOBI 10th Annual PRP & Regenerative Medicine Symposium, Workshops & Cadaver Labs
Estar Medical is delighted to take part in the TOBI congress - a major yearly event for the international orthobiologics community...
FACE – Facial Aesthetic Conference & Exhibition, London, UK
Estar Medical is delighted to take part in the FACE conference and exhibition. UK's premier conference for aesthetic medicine community...
UK High Court Refuses to Grant Regen Lab Permission to Appeal the PRP Patent Revocation Judgement
The UK Court refused to grant Regenlab permission to appeal the finding that its European PRP patent is invalid...